A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

Conditions:   Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Stage IB3 Cervical Cancer FIGO 2018;   Stage II Cervical Cancer FIGO 2018;   Stage IIA Cervical Cancer FIGO 2018;   Stage IIA1 Cervical Cancer FIGO 2018;   Stage IIA2 Cervical Cancer FIGO  2018;   Stage IIB Cervical Cancer FIGO 2018;   Stage III Cervical Cancer FIGO 2018;   Stage IIIA Cervical Cancer FIGO 2018;   Stage IIIB Cervical Cancer FIGO 2018;   Stage IIIC Cervical Cancer FIGO 2018;   Stage IIIC1 Cervical Cancer FIGO 2018;   Stage IIIC2 Ce rvical Cancer FIGO 2018;   Stage IVA Cervical Cancer FIGO 2018 Interventions:   Drug: Cisplatin;   Biological: Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101;   Radiation: Radiation Therapy Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials